MedPath
NMPA Approval

Norepinephrine Bitartrate Injection

国药准字H20244852

September 10, 2024

Drug Information

重酒石酸去甲肾上腺素注射液

注射剂

4ml:8mg

化学药品

September 10, 2024

Company Information

Applicant Company

广州高新技术产业开发区科学城揽月路80号科技创新基地D区第6层601-603单元

Manufacturing Company

成都市海峡两岸科技产业开发园柳台大道222号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.